<DOC>
	<DOCNO>NCT01257737</DOCNO>
	<brief_summary>The present protocol treatment protocol allow continue use HPN-100 treatment UCD subject complete 12 month treatment Study HPN-100-005 , ( NCT00947544 ) , HPN-100-007 , ( NCT00947297 ) , HPN-100-012 , ( NCT01347073 ) . Under protocol , long-term safety continue assess .</brief_summary>
	<brief_title>To Evaluate Safety Long-term Use HPN-100 Management Urea Cycle Disorders ( UCDs )</brief_title>
	<detailed_description>The present protocol allow subject continue use HPN-100 follow treatment study completion Study HPN-100-005 , HPN-100-007 , HPN-100-012 . Subjects able continue study approval commercial availability HPN-100 country participate study . Subjects require return clinic every 6 month physical exam , safety lab , dietary assessment neuropsychological testing occur . Subjects dispense sufficient HPN-100 last next clinic visit .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Urea Cycle Disorders , Inborn</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<criteria>Male female subject complete HPN100005 , ( NCT00947544 ) , HPN100007 , ( NCT00947297 ) , HPN100012 , ( NCT01347073 ) . Signed informed consent subject and/or subject 's legally authorize representative . Negative pregnancy test female childbearing potential . Any clinical laboratory abnormality medical condition , discretion investigator , may put subject increase risk participate . Known hypersensitivity PAA , ( phenylacetate ) PBA , ( phenylbutyrate ) . Liver transplant , include hepatocellular transplant . Pregnant , breastfeed lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Urea Cycle Disorders</keyword>
	<keyword>GT4P</keyword>
	<keyword>HPN-100</keyword>
	<keyword>Sodium Phenylbutyrate</keyword>
	<keyword>Glyceryl tri- ( 4-phenylbutyrate )</keyword>
	<keyword>Phenylbutyrate</keyword>
	<keyword>Hyperion</keyword>
	<keyword>Buphenyl</keyword>
	<keyword>hyperammonemia</keyword>
</DOC>